MEDICAL AND R&D SERVICES
Support for the development and distribution of healthcare and pharmaceutical research and therapeutic methods, as well as therapeutic devices designed to improve quality of life
Therapeutic Areas
We focus on chronic and complex diseases that significantly impact patients’ daily lives. Thanks to advances in biotechnology, our strategy is to provide broader access to the research and information needed for effective therapies. Our work aims to support and inform healthcare professionals and researchers in transforming these diseases into manageable, predictable conditions. primis in faucibus.
SUPPORT FOR BIOSIMILAR DRUG RESEARCH.
What is a biosimilar drug?
A biosimilar drug is a biological medicine that has been developed to be highly similar to an already approved biological medicine (the “reference medicine”).
Biosimilar medicines do not differ significantly from the reference medicine in terms of quality, safety, and efficacy. By competing with originator biologics in an increasing number of therapeutic areas, biosimilars enable stakeholders—including payers, physicians, and patients—to choose from a wider range of treatment options.
RHEUMATOLOGY
ONCOLOGY
AUTOIMMUNE DISEASES
Our support for rheumatology research reflects our commitment to improving the quality of life for the millions of people living with chronic inflammatory diseases. These diseases can cause persistent pain, fatigue, and progressive joint damage, which often limits patients’ daily functioning and independence.
Advances in biotechnology enable the development of targeted therapies that slow disease progression and provide meaningful, long-lasting relief. By supporting research that promotes early and precise intervention, we aim to help healthcare professionals treat diseases more effectively and support patients in maintaining their mobility, independence, and long-term quality of life.
We place a strong emphasis on supporting oncology-focused research initiatives, advancing therapeutic technologies, and improving the quality of life for patients affected by various oncological diseases. Cancer-related conditions often require complex multidisciplinary treatment approaches, continuous monitoring, and innovative therapeutic support systems, making the development and implementation of modern oncology solutions increasingly important for healthcare providers and research institutions alike.
Building on biotechnology, molecular diagnostics, and advanced therapeutic support systems, we contribute to the support of oncology research programs, biosimilar pharmaceutical research initiatives, and translational medical development projects. Special focus is placed on supporting non-clinical research activities, molecular targeting systems, and Chemistry Scale-Up development processes, including PSMA peptide-related research and production support for diagnostic and therapeutic applications.
In addition, we support the testing, deployment, integration, and professional usage training of thermotherapy and hyperthermia-based therapeutic systems utilized in oncology treatment environments. Through educational activities, technical implementation support, and research collaboration initiatives, we aim to help healthcare professionals and medical institutions better understand and utilize advanced thermotherapeutic technologies as complementary treatment approaches within modern oncology care.
By combining research support, educational programs, biotechnology-oriented development, and therapeutic system integration, we strive to contribute to more accessible, efficient, and innovative oncology treatment ecosystems that support both healthcare professionals and patients facing complex oncological challenges.
We place a strong emphasis on training healthcare professionals, supporting research and therapeutic approaches, and improving the quality of life for patients suffering from various autoimmune diseases. These complex diseases, with their unpredictable and persistent symptoms, make daily life difficult, so patients urgently need effective and accessible treatment options that address the underlying immune imbalance.
Building on biotechnology expertise, modern therapies act in a controlled and targeted manner. By providing information and research support to expand access to these treatments, we strive to help healthcare professionals better manage disease activity and make these diseases more predictable and manageable.
OSTEOPOROSIS
THYROID DISEASES
Osteoporosis is a widespread disease that gradually weakens bones and increases the risk of fractures, affecting millions of people worldwide. Because bone loss often develops unnoticed, patients are frequently not diagnosed until a severe fracture occurs.
Advances in biotechnology have expanded therapeutic options, offering targeted treatments that either reduce bone resorption or stimulate new bone formation.
When these therapies are appropriately applied to patients at increased risk of fracture, they can contribute to improving skeletal health and support the maintenance of mobility and independence; our specialists and contracted partners are successfully participating in the development of effective therapies by supporting this research.
We place a strong emphasis on supporting thyroid-related research initiatives and improving the quality of life for individuals affected by various thyroid and endocrine conditions. Through research collaboration, educational support, and biotechnology-oriented initiatives, we aim to contribute to the development of more accessible and patient-focused thyroid care solutions.
In addition, we support the research, development, manufacturing, and distribution of quality-of-life improvement products made from natural ingredients, designed to support general wellbeing and thyroid-related health management. By combining scientific support, natural product innovation, and healthcare-oriented education, we strive to assist healthcare professionals and patients through modern, responsible, and supportive thyroid-focused initiatives.
STRATEGY PARTNERS :
